PL326558A1 - Pure stereoisomers of 3r-3'r zeaxantin for treating human maculopathy - Google Patents

Pure stereoisomers of 3r-3'r zeaxantin for treating human maculopathy

Info

Publication number
PL326558A1
PL326558A1 PL96326558A PL32655896A PL326558A1 PL 326558 A1 PL326558 A1 PL 326558A1 PL 96326558 A PL96326558 A PL 96326558A PL 32655896 A PL32655896 A PL 32655896A PL 326558 A1 PL326558 A1 PL 326558A1
Authority
PL
Poland
Prior art keywords
zeaxantin
maculopathy
treating human
pure stereoisomers
stereoisomers
Prior art date
Application number
PL96326558A
Other versions
PL185465B1 (en
Inventor
Kevin M Garnett
Dennis L Gierhart
Luis H Guerrasantos
Original Assignee
Applied Food Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/551,153 external-priority patent/US5827652A/en
Priority claimed from US08/551,166 external-priority patent/US5854015A/en
Application filed by Applied Food Biotechnology filed Critical Applied Food Biotechnology
Publication of PL326558A1 publication Critical patent/PL326558A1/en
Publication of PL185465B1 publication Critical patent/PL185465B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL96326558A 1995-10-31 1996-10-30 Pure stereoisomers of 3r-3'r zeaxantin for treating human maculopathy PL185465B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/551,153 US5827652A (en) 1995-10-31 1995-10-31 Zeaxanthin formulations for human ingestion
US08/551,166 US5854015A (en) 1995-10-31 1995-10-31 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
PCT/US1996/017563 WO1997016175A1 (en) 1995-10-31 1996-10-30 Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans

Publications (2)

Publication Number Publication Date
PL326558A1 true PL326558A1 (en) 1998-09-28
PL185465B1 PL185465B1 (en) 2003-05-30

Family

ID=27069666

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96326558A PL185465B1 (en) 1995-10-31 1996-10-30 Pure stereoisomers of 3r-3'r zeaxantin for treating human maculopathy

Country Status (14)

Country Link
JP (1) JPH10512594A (en)
KR (1) KR100570251B1 (en)
CN (1) CN1104235C (en)
AR (1) AR004245A1 (en)
AU (1) AU710634B2 (en)
BR (1) BR9611488A (en)
CZ (1) CZ297575B6 (en)
FI (1) FI980947A (en)
HU (1) HU223208B1 (en)
NO (1) NO981698L (en)
PL (1) PL185465B1 (en)
RU (1) RU2197958C2 (en)
WO (1) WO1997016175A1 (en)
ZA (1) ZA969139B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB0501365D0 (en) 2005-01-21 2005-03-02 Promar As Compositions
WO2006086706A2 (en) * 2005-02-11 2006-08-17 Kalamazoo Holdings, Inc. A capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US308759A (en) * 1884-12-02 Curling hat-brims and machine therefor
DE69030817T2 (en) * 1989-08-30 1997-10-16 Applied Food Biotech Inc Process for the preparation of a composition containing zeaxanthin by means of a microorganism of the species Flavobacterium multivorum
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene

Also Published As

Publication number Publication date
WO1997016175A1 (en) 1997-05-09
KR100570251B1 (en) 2006-06-21
CN1201388A (en) 1998-12-09
HU223208B1 (en) 2004-03-29
FI980947A0 (en) 1996-10-30
AU7050196A (en) 1997-05-08
RU2197958C2 (en) 2003-02-10
KR19990067180A (en) 1999-08-16
NO981698D0 (en) 1998-04-16
PL185465B1 (en) 2003-05-30
CZ130998A3 (en) 1998-07-15
CN1104235C (en) 2003-04-02
CZ297575B6 (en) 2007-02-07
JPH10512594A (en) 1998-12-02
ZA969139B (en) 1997-09-25
NO981698L (en) 1998-06-08
BR9611488A (en) 1999-01-19
FI980947A (en) 1998-04-29
AR004245A1 (en) 1998-11-04
HUP9802314A3 (en) 1999-05-28
MX9605248A (en) 1998-06-30
AU710634B2 (en) 1999-09-23
HUP9802314A2 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
EP0746647A4 (en) Mist treatment of garments
AU6513096A (en) Treatment of fabrics
ZA96740B (en) Skin treatment composition
PL324436A1 (en) Novel derivatives of oxazolydinone, method of obtaining them and therapeutic agents containing such compounds
ZA962846B (en) Treatment of traveller's diarrhea
GB9503794D0 (en) Treatment of fabrics
ZA962847B (en) Treatment of traveller's diarrhea.
PL326558A1 (en) Pure stereoisomers of 3r-3'r zeaxantin for treating human maculopathy
IL104755A0 (en) Treatment of glaucoma
IL113057A0 (en) Compositions for the treatment of dandruff
GB9510162D0 (en) Compositions for the treatment of skin conditions
EP0859761A4 (en) 4-azasteroids for treatment of hyperandrogenic conditions
GB2303303B (en) Medical treatment
EP0800396A4 (en) Treatment of hyperandrogenic conditions
GB9218027D0 (en) Novel method of treatment
EP0828507A4 (en) Method for treatment of pain
GB9507825D0 (en) Method of treatment
GB9400600D0 (en) Treatment of motion seckness
ZA961785B (en) Treatment of eczema
GB9216360D0 (en) Treatment of blood
GB9505681D0 (en) "Treatment"
GB9520494D0 (en) Treatment of medical conditions
GB9520495D0 (en) Treatment of medical conditions
GB9520496D0 (en) Treatment of medical conditions
GB2331014B (en) Therapeutic uses of glucan